| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An update on the multimodality of localized rectal cancer
|
Artac, Mehmet
|
|
2016
|
108 |
C |
p. 23-32
10 p.
|
artikel
|
| 2 |
Cancer treatment induced metabolic syndrome: Improving outcome with lifestyle
|
Westerink, N.L.
|
|
2016
|
108 |
C |
p. 128-136
9 p.
|
artikel
|
| 3 |
Dendritic cells in hematological malignancies
|
Galati, Domenico
|
|
2016
|
108 |
C |
p. 86-96
11 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2016
|
108 |
C |
p. IFC-
1 p.
|
artikel
|
| 5 |
Erythropoietin and thrombopoietin mimetics: Natural alternatives to erythrocyte and platelet disorders
|
Gutti, Usha
|
|
2016
|
108 |
C |
p. 175-186
12 p.
|
artikel
|
| 6 |
Hyperglycemia, tumorigenesis, and chronic inflammation
|
Chang, Shu-Chun
|
|
2016
|
108 |
C |
p. 146-153
8 p.
|
artikel
|
| 7 |
Immuno-oncology: Allying forces of radio- and immuno-therapy to enhance cancer cell killing
|
Bernier, Jacques
|
|
2016
|
108 |
C |
p. 97-108
12 p.
|
artikel
|
| 8 |
Lifestyle interventions to improve the quality of life of men with prostate cancer: A systematic review of randomized controlled trials
|
Menichetti, Julia
|
|
2016
|
108 |
C |
p. 13-22
10 p.
|
artikel
|
| 9 |
Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: Where do we stand? A literature review
|
Boussios, Stergios
|
|
2016
|
108 |
C |
p. 164-174
11 p.
|
artikel
|
| 10 |
New molecular therapies in patients with advanced Hepatocellular Cancer in second line of treatment: Is a real defeat?: Results from a literature based meta-analysis of randomized trials
|
Roviello, Giandomenico
|
|
2016
|
108 |
C |
p. 62-68
7 p.
|
artikel
|
| 11 |
Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy
|
Castelli, J.
|
|
2016
|
108 |
C |
p. 40-51
12 p.
|
artikel
|
| 12 |
PARP inhibitor combination therapy
|
Dréan, Amy
|
|
2016
|
108 |
C |
p. 73-85
13 p.
|
artikel
|
| 13 |
Primary immunodeficiencies associated with EBV-Induced lymphoproliferative disorders
|
Shabani, Mahsima
|
|
2016
|
108 |
C |
p. 109-127
19 p.
|
artikel
|
| 14 |
Quality end-of-Life cancer care: An overdue imperative
|
Faguet, Guy B.
|
|
2016
|
108 |
C |
p. 69-72
4 p.
|
artikel
|
| 15 |
Quality indicators in the intensity modulated/image-guided radiotherapy era
|
Gabriele, P.
|
|
2016
|
108 |
C |
p. 52-61
10 p.
|
artikel
|
| 16 |
Routine use of gene panel testing in hereditary breast cancer should be performed with caution
|
van Marcke, Cedric
|
|
2016
|
108 |
C |
p. 33-39
7 p.
|
artikel
|
| 17 |
Targeting mTOR pathway in gynecological malignancies: Biological rationale and systematic review of published data
|
Kassem, Loay
|
|
2016
|
108 |
C |
p. 1-12
12 p.
|
artikel
|
| 18 |
The role of the IGF-1 Ec in myoskeletal system and osteosarcoma pathophysiology
|
Armakolas, Nikolaos
|
|
2016
|
108 |
C |
p. 137-145
9 p.
|
artikel
|
| 19 |
Treatments for colorectal liver metastases: A new focus on a familiar concept
|
Zampino, M.G.
|
|
2016
|
108 |
C |
p. 154-163
10 p.
|
artikel
|
Tijdschrift beschrijving